WallStSmart
MRM

Medirom Healthcare Technologies Inc

NASDAQ: MRM · CONSUMER CYCLICAL · PERSONAL SERVICES

$1.03
-5.04% today

Updated 2026-06-05

Market cap
$8.93M
P/E ratio
3.05
P/S ratio
0.00x
EPS (TTM)
$0.37
Dividend yield
52W range
$1 – $4
Volume
0.4M

Medirom Healthcare Technologies Inc (MRM) Financial statements

SEC filings — annual and quarterly data.

Profit margin
9.27%
Operating margin
10.25%
ROE
63.91%
ROA
-1.78%
Debt/equity
1.75x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2018$3.43B$66.31M27.87%2.13%1.93%
2019$3.91B$17.34M24.33%0.88%0.44%
2020$3.34B$-539.17M12.84%-22.33%-16.14%
2021$5.41B$-990.73M26.16%-7.02%-18.31%
2022$6.95B$148.97M27.36%1.39%2.14%
2023$6.83B$115.05M22.98%-5.73%1.68%
2024$8.30B$148.76M27.07%-0.22%1.79%
2025$4.04M$374720.0096.59%10.25%9.27%

Frequently asked questions

What is Medirom Healthcare Technologies Inc's revenue?

Medirom Healthcare Technologies Inc's trailing twelve-month revenue is $8.07B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MRM?

In its most recent fiscal year, MRM ran a gross margin of 96.59%, an operating margin of 10.25%, and a net margin of 9.27%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MRM generate?

MRM produced $-1.90B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MRM's balance sheet healthy?

MRM holds $20.14M in cash and equivalents against — in long-term debt, on $1.33B of shareholder equity. That debt is best read against the cash flow the business throws off each year.